41 related articles for article (PubMed ID: 33993615)
1. Mechanism of Viral Glycoprotein Targeting by Membrane-associated-RING-CH Proteins.
Lun CM; Waheed AA; Majadly A; Powell N; Freed EO
bioRxiv; 2021 Jan; ():. PubMed ID: 33532773
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Antiviral Mechanism of Different MARCH Factors.
Umthong S; Lynch B; Timilsina U; Waxman B; Ivey EB; Stavrou S
mBio; 2021 Mar; 12(2):. PubMed ID: 33653895
[TBL] [Abstract][Full Text] [Related]
3. MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells.
Chen W; Patel D; Jia Y; Yu Z; Liu X; Shi H; Liu H
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067416
[TBL] [Abstract][Full Text] [Related]
4. Determining the antiviral mechanism of MARCH2.
Umthong S; Timilsina U; D'Angelo M; Stavrou S
bioRxiv; 2023 Sep; ():. PubMed ID: 37786722
[TBL] [Abstract][Full Text] [Related]
5. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes.
Liu X; Xu F; Ren L; Zhao F; Huang Y; Wei L; Wang Y; Wang C; Fan Z; Mei S; Song J; Zhao Z; Cen S; Liang C; Wang J; Guo F
Nat Commun; 2021 Jul; 12(1):4427. PubMed ID: 34285233
[TBL] [Abstract][Full Text] [Related]
6. Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes.
Tada T; Dcosta BM; Samanovic MI; Herati RS; Cornelius A; Zhou H; Vaill A; Kazmierski W; Mulligan MJ; Landau NR
mBio; 2021 Jun; 12(3):e0069621. PubMed ID: 34060334
[TBL] [Abstract][Full Text] [Related]
7. Further Characterization of the Antiviral Transmembrane Protein MARCH8.
Tada T; Zhang Y; Kong D; Tanaka M; Yao W; Kameoka M; Ueno T; Fujita H; Tokunaga K
Cells; 2024 Apr; 13(8):. PubMed ID: 38667313
[TBL] [Abstract][Full Text] [Related]
8. Membrane-Associated Ubiquitin Ligase RING Finger Protein 152 Orchestrates Melanogenesis via Tyrosinase Ubiquitination.
Ueda R; Hashimoto R; Fujii Y; Menezes JCJMDS; Takahashi H; Takeda H; Sawasaki T; Motokawa T; Tokunaga K; Fujita H
Membranes (Basel); 2024 Feb; 14(2):. PubMed ID: 38392670
[TBL] [Abstract][Full Text] [Related]
9. Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage.
Yu C; Wang G; Liu Q; Zhai J; Xue M; Li Q; Xian Y; Zheng C
Emerg Microbes Infect; 2023 Dec; 12(1):2164742. PubMed ID: 36591809
[TBL] [Abstract][Full Text] [Related]
10. Host Restriction Factors Modulating HIV Latency and Replication in Macrophages.
Pagani I; Demela P; Ghezzi S; Vicenzi E; Pizzato M; Poli G
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328442
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.
Lun CM; Waheed AA; Majadly A; Powell N; Freed EO
mBio; 2021 Mar; 12(2):. PubMed ID: 33727347
[TBL] [Abstract][Full Text] [Related]
12. [Identification of an antiviral host transmembrane protein MARCH8].
Tokunaga K
Uirusu; 2015; 65(2):173-178. PubMed ID: 27760915
[TBL] [Abstract][Full Text] [Related]
13. MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.
Tada T; Zhang Y; Koyama T; Tobiume M; Tsunetsugu-Yokota Y; Yamaoka S; Fujita H; Tokunaga K
Nat Med; 2015 Dec; 21(12):1502-7. PubMed ID: 26523972
[TBL] [Abstract][Full Text] [Related]
14. MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.
Zhang Y; Ozono S; Tada T; Tobiume M; Kameoka M; Kishigami S; Fujita H; Tokunaga K
Microbiol Spectr; 2022 Feb; 10(1):e0061821. PubMed ID: 35019698
[TBL] [Abstract][Full Text] [Related]
15. The emerging roles of MARCH8 in viral infections: A double-edged Sword.
Yu C; Liu Q; Zhao Z; Zhai J; Xue M; Tang YD; Wang C; Zheng C
PLoS Pathog; 2023 Sep; 19(9):e1011619. PubMed ID: 37708148
[TBL] [Abstract][Full Text] [Related]
16. MARCH8: the tie that binds to viruses.
Tada T; Zhang Y; Fujita H; Tokunaga K
FEBS J; 2022 Jul; 289(13):3642-3654. PubMed ID: 33993615
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
